World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders
- PMID: 35900161
- DOI: 10.1080/15622975.2022.2086295
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders
Abstract
Aim: This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (published in 2002, revised in 2008).
Method: A consensus panel of 33 international experts representing 22 countries developed recommendations based on efficacy and acceptability of available treatments. In total, 1007 RCTs for the treatment of these disorders in adults, adolescents, and children with medications, psychotherapy and other non-pharmacological interventions were evaluated, applying the same rigorous methods that are standard for the assessment of medications.
Result: This paper, Part I, contains recommendations for the treatment of panic disorder/agoraphobia (PDA), generalised anxiety disorder (GAD), social anxiety disorder (SAD), specific phobias, mixed anxiety disorders in children and adolescents, separation anxiety and selective mutism. Selective serotonin reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are first-line medications. Cognitive behavioural therapy (CBT) is the first-line psychotherapy for anxiety disorders. The expert panel also made recommendations for patients not responding to standard treatments and recommendations against interventions with insufficient evidence.
Conclusion: It is the goal of this initiative to provide treatment guidance for these disorders that has validity throughout the world.
Keywords: Anxiety disorders; adolescents; children; guideline; treatment.
Similar articles
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD.World J Biol Psychiatry. 2023 Feb;24(2):118-134. doi: 10.1080/15622975.2022.2086296. Epub 2022 Jul 28. World J Biol Psychiatry. 2023. PMID: 35900217
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.World J Biol Psychiatry. 2008;9(4):248-312. doi: 10.1080/15622970802465807. World J Biol Psychiatry. 2008. PMID: 18949648
-
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care.Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. doi: 10.3109/13651501.2012.667114. Epub 2012 Apr 30. Int J Psychiatry Clin Pract. 2012. PMID: 22540422
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.World J Biol Psychiatry. 2002 Oct;3(4):171-99. doi: 10.3109/15622970209150621. World J Biol Psychiatry. 2002. PMID: 12516310 Review.
-
Treatment of Anxiety Disorders: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2005 Nov. SBU Yellow Report No. 171/1+2. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2005 Nov. SBU Yellow Report No. 171/1+2. PMID: 28876726 Free Books & Documents. Review.
Cited by
-
The Impact on Anxiety Symptoms of an Immersive Virtual Reality Remediation Program in Bipolar Disorders: A Randomized Clinical Trial.J Clin Med. 2024 Jul 18;13(14):4203. doi: 10.3390/jcm13144203. J Clin Med. 2024. PMID: 39064243 Free PMC article.
-
Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review.EClinicalMedicine. 2024 Mar 13;70:102507. doi: 10.1016/j.eclinm.2024.102507. eCollection 2024 Apr. EClinicalMedicine. 2024. PMID: 38516102 Free PMC article.
-
Development of decision rules for an adaptive aftercare intervention based on individual symptom courses for agoraphobia patients.Sci Rep. 2024 Feb 6;14(1):3056. doi: 10.1038/s41598-024-52803-z. Sci Rep. 2024. PMID: 38321070 Free PMC article.
-
The definition of treatment resistance in anxiety disorders: a Delphi method-based consensus guideline.World Psychiatry. 2024 Feb;23(1):113-123. doi: 10.1002/wps.21177. World Psychiatry. 2024. PMID: 38214637 Free PMC article.
-
Efficacy and safety of the Chinese herbal medicine Xiao Yao San for treating anxiety: a systematic review with meta-analysis and trial sequential analysis.Front Pharmacol. 2023 Oct 12;14:1169292. doi: 10.3389/fphar.2023.1169292. eCollection 2023. Front Pharmacol. 2023. PMID: 37905203 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical